70
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Determinants of Health-Related Quality of Life in Outpatients with Myocardial Infarction

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2133-2145 | Received 11 Feb 2024, Accepted 29 Apr 2024, Published online: 06 May 2024

References

  • Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
  • Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: a Report From the American Heart Association. Circulation. 2019;139(10):e56–e528. doi:10.1161/CIR.0000000000000659
  • WHO EMRO Jordan implements WHO HEARTS in primary health care to strengthen management of cardiovascular diseases and related risks | jordan-infocus | jordan. Available from: https://www.emro.who.int/jor/jordan-infocus/jordan-implements-who-hearts-in-primary-health-care-to-strengthen-management-of-cardiovascular-diseases-and-related-risks.html. Accessed January 1, 2022.
  • Nsour M, Mahfoud Z, Kanaan MN, Balbeissi A. Prevalence and predictors of nonfatal myocardial infarction in Jordan. East Mediterr Health J. 2008;14(4):818–830.
  • Jordan. The Institute for Health Metrics and Evaluation. Available from: https://www.healthdata.org/research-analysis/health-by-location/profiles/jordan. Accessed January 1, 2022.
  • Subih M, AlBarmawi M, Bashir DY, Jacoub SM, Sayyah NS. Correlation between quality of life of cardiac patients and caregiver burden. PLoS One. 2020;15(8):e0237099. doi:10.1371/JOURNAL.PONE.0237099
  • Wang OJ, Wang Y, Chen J, Krumholz HM. Recent trends in hospitalization for acute myocardial infarction. Am J Cardiol. 2012;109(11):1589–1593. doi:10.1016/j.amjcard.2012.01.381
  • Bishu KG, Lekoubou A, Kirkland E, et al. Estimating the Economic Burden of Acute Myocardial Infarction in the US: 12 Year National Data. Am J Med Sci. 2020;359(5):257–265. doi:10.1016/j.amjms.2020.02.004
  • Rathore V, Singh N, Mahat RK. Risk Factors of Acute Myocardial Infarction: a Review. Eurasian J Med Investigation. 2018;2(1):1–7. doi:10.14744/ejmi.2018.76486
  • Lu L, Liu M, Sun R, Zheng Y, Zhang P. Myocardial Infarction: symptoms and Treatments. Cell Biochem Biophys. 2015;72(3):865–867. doi:10.1007/s12013-015-0553-4
  • Eshah NF. Seeking Medical Attention among Jordanian Patients with Acute Myocardial Infarction. Eur J Sci Res. 2013;3:753–761.
  • Abuelhaija Y, Mustafa A, Mahmoud MY, et al. A systematic review on the healthcare system in Jordan: strengths, weaknesses, and opportunities for improvement. World J Adv Res Rev. 2023;18(3):1393–1396. doi:10.30574/wjarr.2023.18.3.1254
  • Health-Related Quality of Life & Well-Being. Healthy People 2020. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/health-related-quality-of-life-well-being. Accessed May 1, 2024.
  • Boersma SN, Maes S, Joekes K, Dusseldorp E. Goal processes in relation to goal attainment: predicting health-related quality of life in myocardial infarction patients. J Health Psychol. 2006;11(6):927–941. doi:10.1177/1359105306069095
  • Munyombwe T, Dondo TB, Aktaa S, et al. Association of multimorbidity and changes in health-related quality of life following myocardial infarction: a UK multicentre longitudinal patient-reported outcomes study. BMC Med. 2021;19(1):227. doi:10.1186/s12916-021-02098-y
  • Benyamini Y, Roziner I, Goldbourt U, Drory Y, Gerber Y. Depression and anxiety following myocardial infarction and their inverse associations with future health behaviors and quality of life. Ann Behav Med. 2013;46(3):310–321. doi:10.1007/s12160-013-9509-3
  • Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med. 2001;63(2):221–230. doi:10.1097/00006842-200103000-00005
  • Kim HM, Kim J, Hwang SY. Health-related quality of life in symptomatic postmyocardial infarction patients with left ventricular dysfunction. Asian Nurs Res. 2015;9(1):47–52. doi:10.1016/j.anr.2014.11.004
  • Hosseini SH, Ghaemian A, Mehdizadeh E, Ashraf H. Contribution of depression and anxiety to impaired quality of life in survivors of myocardial infarction. Int J Psychiatry Clin Pract. 2014;18(3):175–181. doi:10.3109/13651501.2014.940049
  • Wang W, Thompson DR, Ski CF, Liu M. Health-related quality of life and its associated factors in Chinese myocardial infarction patients. Eur J Prev Cardiol. 2014;21(3):321–329. doi:10.1177/2047487312454757
  • Wang W, Chow A, Thompson DR, Koh K, Kowitlawakul Y, He HG. Predictors of Health-Related Quality of Life Among Patients With Myocardial Infarction. West J Nurs Res. 2016;38(1):43–56. doi:10.1177/0193945914546201
  • Uchmanowicz I, Loboz-Grudzien K, Jankowska-Polanska B, Sokalski L. Influence of diabetes on health-related quality of life results in patients with acute coronary syndrome treated with coronary angioplasty. Acta Diabetol. 2013;50(2):217–225. doi:10.1007/s00592-011-0280-2
  • Arnold SV, Masoudi FA, Rumsfeld JS, Li Y, Jones PG, Spertus JA. Derivation and validation of a risk standardization model for benchmarking hospital performance for health-related quality of life outcomes after acute myocardial infarction. Circulation. 2014;129(3):313–320. doi:10.1161/CIRCULATIONAHA.113.001773
  • Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368–e454. doi:10.1161/CIR.0000000000001029
  • Awwad O, AlMuhaissen S, Al-Nashwan A, AbuRuz S. Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale. PLoS One. 2022;17(10):e0275778–e0275778. doi:10.1371/journal.pone.0275778
  • Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24. doi:10.1080/08870449908407311
  • Al-Qerem W, Al Bawab AQ, Abusara O, Alkhatib N, Horne R. Validation of the Arabic version of medication adherence report scale questionnaire and beliefs about medication -specific questionnaire: a factor analysis study. PLoS One. 2022;17(4):e0266606. doi:10.1371/journal.pone.0266606
  • Group E. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-9
  • Aburuz S, Bulatova N, Twalbeh M, Gazawi M. The validity and reliability of the Arabic version of the EQ-5D: a study from Jordan. Ann Saudi Med. 2009;29(4):304–308. doi:10.4103/0256-4947.55313
  • Zhang M, Chen P, Zhang Y, et al. Predictors of Quality of Life in Patients With Myocardial Infarction Combined With Dyslipidemia. Front Public Health. 2021;9:713480. doi:10.3389/fpubh.2021.713480
  • Lomwong P, Paochitkul K, Rinnanont P, et al. Health-Related Quality of Life in Patients with Acute Myocardial Infarction during Admission and six months after Admission. Bangk Med J. 2022;18(1):22–27. doi:10.31524/bkkmedj.2022.11.004
  • Hurdus B, Munyombwe T, Dondo TB, et al. Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction. Heart. 2020;106:1726–1731. doi:10.1136/heartjnl-2020-316920
  • Pocock S, Brieger DB, Owen R, et al. Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis. Open Heart. 2021;8(1):e001499. doi:10.1136/openhrt-2020-001499
  • Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8(1):13. doi:10.1186/1477-7525-8-13
  • Kaur R. A Descriptive Study Done to Assess the Quality of Life among Post Myocardial Infarction Patients Attending Cardiac OPDs. Women’s Health. 2017;4(6):146–151. doi:10.15406/mojwh.2017.04.00103
  • Kang K, Gholizadeh L, Inglis SC, Han HR. Correlates of health-related quality of life in patients with myocardial infarction: a literature review. Int J Nurs Stud. 2017;73:1–16. doi:10.1016/j.ijnurstu.2017.04.010
  • Bahall M, Khan K. Quality of life of patients with first-time AMI: a descriptive study. Health Qual Life Outcomes. 2018;16(1):32. doi:10.1186/s12955-018-0860-8
  • Jarab AS, Almousa A, Rababa’h AM, Mukattash TL, Farha RA. Health-related quality of life and its associated factors among patients with angina in Jordan. Qual Life Res. 2020;29(4):1027–1035. doi:10.1007/s11136-019-02383-7
  • Jarab AS, Alefishat E, Mukattash TL, Albawab AQ, Abu-Farha RK, McElnay JC. Exploring variables associated with poor health-related quality of life in patients with type 2 diabetes in Jordan. J Pharm Health Serv Res. 2019;10(2):211–217. doi:10.1111/jphs.12255
  • White J, Hunter M, Holttum S. How do women experience myocardial infarction? A qualitative exploration of illness perceptions, adjustment and coping. Psychol Health Med. 2007;12(3):278–288. doi:10.1080/13548500600971288
  • Kang K, Gholizadeh L, Han HR. Health-related Quality of Life and Its Predictors in Korean Patients with Myocardial Infarction in the Acute Phase. Clin Nurs Res. 2021;30(2):161–170. doi:10.1177/1054773819894692
  • Tan MC, Ng OC, Wong TW, Hejar AR, Anthony J, Sintonen H. The association of cardiovascular disease with impaired health-related quality of life among patients with type 2 diabetes mellitus. Singapore Med J. 2014;55(4):209–216. doi:10.11622/smedj.2014054
  • Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care. 1997;20(3):299–305. doi:10.2337/diacare.20.3.299
  • Peña-Longobardo LM, Rodríguez-Sánchez B, Mata-Cases M, Rodríguez-Mañas L, Capel M, Oliva-Moreno J. Is quality of life different between diabetic and non-diabetic people? The importance of cardiovascular risks. PLoS One. 2017;12(12):e0189505. doi:10.1371/journal.pone.0189505
  • Guhl E, Althouse A, Sharbaugh M, Pusateri AM, Paasche-Orlow M, Magnani JW. Association of income and health-related quality of life in atrial fibrillation. Open Heart. 2019;6(1):1–8. doi:10.1136/openhrt-2018-000974
  • Du R, Wang P, Ma L, et al. Health-related quality of life and associated factors in patients with myocardial infarction after returning to work: a cross-sectional study. Health Qual Life Outcomes. 2020;18(1):190. doi:10.1186/s12955-020-01447-4
  • Jarab AS, Hamam HW, Al-Qerem WA, Abu Heshmeh SR, Mukattash TL, Alefishat EA. Health-related quality of life and its associated factors among outpatients with heart failure: a cross-sectional study. Health Qual Life Outcomes. 2023;21(1):73. doi:10.1186/s12955-023-02142-w
  • Alefishat E, Jarab S, Abu Farha A. Factors affecting health-related quality of life among hypertensive patients using the EQ-5D tool. Int J Clin Pract. 2020;74(9):e13532. doi:10.1111/ijcp.13532
  • Hamid HA, Ho WSG. Demarcating Households: an Integrated Analysis of Income and Consumption. Khazanah Research Institute. 2019;19(Suppl 4).
  • Wang MT, Lin SC, Tang PL, et al. The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction. Cardiovasc Diabetol. 2017;16(1):1–11. doi:10.1186/s12933-017-0572-0
  • Chinda K, Palee S, Surinkaew S, Phornphutkul M, Chattipakorn S, Chattipakorn N. Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury. Int J Cardiol. 2013;167(2):451–457. doi:10.1016/J.IJCARD.2012.01.011
  • Kubota A, Takano H, Wang H, et al. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction. J Mol Cell Cardiol. 2016;91:72–80. doi:10.1016/J.YJMCC.2015.12.026
  • Ervinna N, Mita T, Yasunari E, et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice. Endocrinology. 2013;154(3):1260–1270. doi:10.1210/EN.2012-1855
  • Hirano T, Mori Y. Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and dipeptidyl peptidase-4 inhibitors in experimental animals. J Diabetes Investig. 2016;7 Suppl 1(Suppl 1):80–86. doi:10.1111/JDI.12446
  • Kato S, Fukui K, Kirigaya H, et al. Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease. Int J Cardiol. 2016;223:770–775. doi:10.1016/J.IJCARD.2016.08.306
  • Monami M, Dicembrini I, Martelli D, Mannucci E. Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials. Curr Med Res Opin. 2011;27 Suppl 3(SUPPL. 3):57–64. doi:10.1185/03007995.2011.602964
  • Fogel J, Fauerbach JA, Ziegelstein RC, Bush DE. Quality of life in physical health domains predicts adherence among myocardial infarction patients even after adjusting for depressive symptoms. J Psychosom Res. 2004;56(1):75–82. doi:10.1016/S0022-3999(03)00563-4
  • Krack G, Holle R, Kirchberger I, Kuch B, Amann U, Seidl H. Determinants of adherence and effects on health-related quality of life after myocardial infarction: a prospective cohort study. BMC Geriatr. 2018;18(1):136. doi:10.1186/s12877-018-0827-y
  • Wu JR, Moser DK. Health-Related Quality of Life Is a Mediator of the Relationship Between Medication Adherence and Cardiac Event-Free Survival in Patients with Heart Failure. J Card Fail. 2021;27(8):848–856. doi:10.1016/j.cardfail.2021.03.004
  • Ibrahim KM, Schommer JC, Morisky DE, Rodriguez R, Gaither C, Snyder M. The Association between Medication Experiences and Beliefs and Low Medication Adherence in Patients with Chronic Disease from Two Different Societies: the USA and the Sultanate of Oman. Pharmacy. 2021;9(1):31. doi:10.3390/pharmacy9010031
  • Neter E, Glass-Marmor L, Wolkowitz A, Lavi I, Miller A. Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis. BMC Neurol. 2021;21(1):136. doi:10.1186/s12883-021-02149-0